90 related articles for article (PubMed ID: 11667469)
1. Total Synthesis of Cryptophycins and Their 16-(3-Phenylacryloyl) Derivatives.
Rej R; Nguyen D; Go B; Fortin S; Lavallée JF
J Org Chem; 1996 Sep; 61(18):6289-6295. PubMed ID: 11667469
[TBL] [Abstract][Full Text] [Related]
2. Cryptophycins: a novel class of potent antimitotic antitumor depsipeptides.
Shih C; Teicher BA
Curr Pharm Des; 2001 Sep; 7(13):1259-76. PubMed ID: 11472266
[TBL] [Abstract][Full Text] [Related]
3. Isolation and structure determination of cryptophycins 38, 326, and 327 from the terrestrial cyanobacterium Nostoc sp. GSV 224.
Chaganty S; Golakoti T; Heltzel C; Moore RE; Yoshida WY
J Nat Prod; 2004 Aug; 67(8):1403-6. PubMed ID: 15332864
[TBL] [Abstract][Full Text] [Related]
4. A Versatile Chemoenzymatic Synthesis for the Discovery of Potent Cryptophycin Analogs.
Schmidt JJ; Khatri Y; Brody SI; Zhu C; Pietraszkiewicz H; Valeriote FA; Sherman DH
ACS Chem Biol; 2020 Feb; 15(2):524-532. PubMed ID: 31961651
[TBL] [Abstract][Full Text] [Related]
5. Cryptophycins-309, 249 and other cryptophycin analogs: preclinical efficacy studies with mouse and human tumors.
Liang J; Moore RE; Moher ED; Munroe JE; Al-awar RS; Hay DA; Varie DL; Zhang TY; Aikins JA; Martinelli MJ; Shih C; Ray JE; Gibson LL; Vasudevan V; Polin L; White K; Kushner J; Simpson C; Pugh S; Corbett TH
Invest New Drugs; 2005 Jun; 23(3):213-24. PubMed ID: 15868377
[TBL] [Abstract][Full Text] [Related]
6. Three new cryptophycins from Nostoc sp. GSV 224.
Subbaraju GV; Golakoti T; Patterson GM; Moore RE
J Nat Prod; 1997 Mar; 60(3):302-5. PubMed ID: 9090872
[TBL] [Abstract][Full Text] [Related]
7. Cryptophycins: cytotoxic cyclodepsipeptides with potential for tumor targeting.
Weiss C; Figueras E; Borbely AN; Sewald N
J Pept Sci; 2017 Jul; 23(7-8):514-531. PubMed ID: 28661555
[TBL] [Abstract][Full Text] [Related]
8. Total synthesis and biological evaluation of fluorinated cryptophycins.
Weiß C; Bogner T; Sammet B; Sewald N
Beilstein J Org Chem; 2012; 8():2060-6. PubMed ID: 23209540
[TBL] [Abstract][Full Text] [Related]
9. Analysis of the cryptophycin P450 epoxidase reveals substrate tolerance and cooperativity.
Ding Y; Seufert WH; Beck ZQ; Sherman DH
J Am Chem Soc; 2008 Apr; 130(16):5492-8. PubMed ID: 18366166
[TBL] [Abstract][Full Text] [Related]
10. Total Synthesis of Cryptophycins via a Chemoenzymatic Approach.
Salamonczyk GM; Han K; Guo Zw ZW; Sih CJ
J Org Chem; 1996 Oct; 61(20):6893-6900. PubMed ID: 11667584
[TBL] [Abstract][Full Text] [Related]
11. Recent approaches for the synthesis of modified cryptophycins.
Weiss C; Sammet B; Sewald N
Nat Prod Rep; 2013 Jul; 30(7):924-40. PubMed ID: 23732943
[TBL] [Abstract][Full Text] [Related]
12. Efficient and versatile stereoselective synthesis of cryptophycins.
Mast CA; Eissler S; Stoncius A; Stammler HG; Neumann B; Sewald N
Chemistry; 2005 Aug; 11(16):4667-77. PubMed ID: 15915529
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics and tissue distribution of cryptophycin 52 (C-52) epoxide and cryptophycin 55 (C-55) chlorohydrin in mice with subcutaneous tumors.
Boinpally RR; Polin L; Zhou SL; Jasti BR; Wiegand RA; White K; Kushner J; Horwitz JP; Corbett TH; Parchment RE
Cancer Chemother Pharmacol; 2003 Jul; 52(1):25-33. PubMed ID: 12739061
[TBL] [Abstract][Full Text] [Related]
14. Binding of the epoxide cryptophycin analog, LY355703 to albumin and its effect on in vitro antiproliferative activity.
Schultz RM; Shih C; Wood PG; Harrison SD; Ehlhardt WJ
Oncol Rep; 1998; 5(5):1089-94. PubMed ID: 9683814
[TBL] [Abstract][Full Text] [Related]
15. Approaches for the synthesis of functionalized cryptophycins.
Sammet B; Bogner T; Nahrwold M; Weiss C; Sewald N
J Org Chem; 2010 Oct; 75(20):6953-60. PubMed ID: 20857920
[TBL] [Abstract][Full Text] [Related]
16. Antitumor activity of cryptophycins: effect of infusion time and combination studies.
Menon K; Alvarez E; Forler P; Phares V; Amsrud T; Shih C; Al-Awar R; Teicher BA
Cancer Chemother Pharmacol; 2000; 46(2):142-9. PubMed ID: 10972484
[TBL] [Abstract][Full Text] [Related]
17. Biosynthetic characterization and chemoenzymatic assembly of the cryptophycins. Potent anticancer agents from cyanobionts.
Magarvey NA; Beck ZQ; Golakoti T; Ding Y; Huber U; Hemscheidt TK; Abelson D; Moore RE; Sherman DH
ACS Chem Biol; 2006 Dec; 1(12):766-79. PubMed ID: 17240975
[TBL] [Abstract][Full Text] [Related]
18. Asymmetric Syntheses of Potent Antitumor Macrolides Cryptophycin B and Arenastatin A.
Ghosh AK; Bischoff A
European J Org Chem; 2004 May; 2004(10):2131-2141. PubMed ID: 30443158
[TBL] [Abstract][Full Text] [Related]
19. Efficient synthesis of cryptophycin-52 and novel para-alkoxymethyl unit A analogues.
Eissler S; Bogner T; Nahrwold M; Sewald N
Chemistry; 2009 Oct; 15(42):11273-87. PubMed ID: 19760734
[TBL] [Abstract][Full Text] [Related]
20. Interaction of cryptophycin 1 with tubulin and microtubules.
Kerksiek K; Mejillano MR; Schwartz RE; Georg GI; Himes RH
FEBS Lett; 1995 Dec; 377(1):59-61. PubMed ID: 8543019
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
